{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:22:31Z","timestamp":1780626151542,"version":"3.54.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T00:00:00Z","timestamp":1666569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T00:00:00Z","timestamp":1666569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GL1804"],"award-info":[{"award-number":["01GL1804"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol. Res. Pract."],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In the treatment of status epilepticus less is known about the influence of comorbidities on the safety profile of anticonvulsive drugs. Especially patients with diabetes mellitus may be predisposed to certain adverse events that have been related to therapy with valproic acid. In this single-center retrospective cohort study we examined if the complications of the intravenous treatment with valproic acid is different in patients with or without diabetes.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients who were treated for status epilepticus with intravenous valproic acid between 2008 and 2020 were identified. Primary endpoint was the discontinuation of therapy with valproic acid due to adverse events. Relevant secondary endpoints were the functional status at the time of discharge from hospital in comparison to the premorbid state and the in-hospital mortality. Both groups (patients with or without diabetes) were compared by Mann\u2013Whitney U-Test or Pearson\u00b4s Chi<jats:sup>2<\/jats:sup> test. To identify therapy with valproic acid as a risk factor of in-hospital mortality, a binary regression model was used.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>During the study period 408 patients and 482 episodes of status epilepticus were treated with intravenous valproic acid. Group comparisons did not reveal a significant difference in the rates of discontinuation of therapy. A difference was found in the rate of thrombocytopenia (<jats:italic>p<\/jats:italic>\u2009=\u20090.015), which occurred more often in patients with diabetes. In total, 36 hypoglycemic episodes could be identified, two occurred spontaneously under intravenous valproic acid. After correction for potential confounders, continuous therapy with valproic acid could not be confirmed as an independent risk factor for in-hospital mortality (<jats:italic>p<\/jats:italic>\u2009=\u20090.079). In patients with diabetes, the proportion of patients with a good functional state, indicated by the modified Rankin Scale, was significantly lower in both times (premorbid: 55% vs. 69%, <jats:italic>p<\/jats:italic>\u2009=\u20090.008; at discharge: 22% vs. 36%, <jats:italic>p<\/jats:italic>\u2009=\u20090.004).\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Tolerability of the treatment with valproic acid was similar in patients with or without diabetes. Diabetes as a relevant comorbidity can signal a potentially increased risk of a poor outcome after status epilepticus.<\/jats:p>\n                <jats:p><jats:italic>Trial registration<\/jats:italic>: The study was registered at the German Clinical Trials Register on 8 April 2022 (DRKS 00,027,836).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s42466-022-00212-w","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T22:03:42Z","timestamp":1668117822000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Does diabetes mellitus affect the safety profile of valproic acid for the treatment of status epilepticus? A retrospective cohort study"],"prefix":"10.1186","volume":"4","clinical-trial-number":[{"clinical-trial-number":"drks00027836","registry":"10.18810\/drks"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8007-6846","authenticated-orcid":false,"given":"Annekatrin","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"von Hofen-Hohloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Awissus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Przybilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achmed","family":"Mrestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Classen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,24]]},"reference":[{"key":"212_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.eplepsyres.2017.07.006","volume":"136","author":"RJ Lv","year":"2017","unstructured":"Lv, R. J., Qun, W., Cui, T., Zhu, F., & Shao, X. Q. (2017). Status epilepticus-related etiology, incidence and mortality: A meta-analysis. Epilepsy Research, 136, 12\u201317.","journal-title":"Epilepsy Research"},{"issue":"10","key":"212_CR2","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1007\/s00415-008-0989-1","volume":"255","author":"AO Rossetti","year":"2008","unstructured":"Rossetti, A. O., Logroscino, G., Milligan, T. A., Michaelides, C., Ruffieux, C., & Bromfield, E. B. (2008). Status epilepticus severity score (STESS): a tool to orient early treatment strategy. Journal of Neurology, 255(10), 1561\u20131566.","journal-title":"Journal of Neurology"},{"key":"212_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.seizure.2019.11.003","volume":"74","author":"C Reindl","year":"2020","unstructured":"Reindl, C., Spr\u00fcgel, M. I., Sembill, J. A., Mueller, T. M., Hagen, M., Gerner, S. T., Kuramatsu, J. B., Hamer, H. M., Huttner, H. B., & Madzar, D. (2020). Influence of new versus traditional antiepileptic drugs on course and outcome of status epilepticus. Seizure, 74, 20\u201325.","journal-title":"Seizure"},{"issue":"2","key":"212_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12028-014-0080-y","volume":"22","author":"M Leitinger","year":"2015","unstructured":"Leitinger, M., H\u00f6ller, G., Kalss, G., Rohracher, A., Novak, H. F., H\u00f6fler, J., Dobesberger, J., Kuchukhidze, G., & Trinke, E. (2015). Epidemology-based mortality score in status epilepticus (EMSE). Neurocritical Care, 22(2), 273\u2013282.","journal-title":"Neurocritical Care"},{"issue":"7","key":"212_CR5","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s40263-014-0167-1","volume":"28","author":"E Trinka","year":"2014","unstructured":"Trinka, E., H\u00f6fler, J., Zerbs, A., & Brigo, F. (2014). Efficacy and safety of intravenous valproate for status epilepticus: a systematic review. CNS Drugs, 28(7), 623\u2013639.","journal-title":"CNS Drugs"},{"issue":"3","key":"212_CR6","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1468-1331.2009.02917.x","volume":"17","author":"H Meierkord","year":"2010","unstructured":"Meierkord, H., Boon, P., Engelsen, B., G\u00f6cle, K., Shorvon, S., Tinuper, P., Holtkamp, M., European Federation of Neurological Societies. (2010). EFNS guideline on the management of status epilepticus in adults. European Journal of Neurology, 17(3), 348\u2013355.","journal-title":"European Journal of Neurology"},{"key":"212_CR7","doi-asserted-by":"publisher","first-page":"106675","DOI":"10.1016\/j.yebeh.2019.106675","volume":"102","author":"F Minicucci","year":"2020","unstructured":"Minicucci, F., Ferlisi, M., Brigo, D., Mecarelli, O., Meletti, S., Aguglia, A., Michelucci, R., Mastrangelo, M., Specchio, N., Sartori, S., & Tinuper, P. (2020). Management of status epilepticus in adults. Position paper of the Italian League against Epilepsy. Epilepsy and Behavior, 102, 106675.","journal-title":"Epilepsy and Behavior"},{"key":"212_CR8","doi-asserted-by":"crossref","unstructured":"Leitlinie. Deutsche Gesellschaft f\u00fcr Neurologie. Status epilepticus im Erwachsenenalter. https:\/\/dgn.org\/leitlinien\/030-079-status-epilepticus-im-erwachsenenalter-2020\/.","DOI":"10.1007\/978-3-662-59198-7_60"},{"issue":"22","key":"212_CR9","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1905795","volume":"381","author":"J Kapur","year":"2019","unstructured":"Kapur, J., Elm, J., Chamberlain, J. M., Barsan, W., Cloyd, J., Lowenstein, D., Shinnar, S., Conwit, R., Meinzer, C., Cock, H., Fountain, N., Connor, J. T., Silbergleit, R., NETT and PECARN Investigators. (2019). Randomized trial of three anticonvulsant medications for status epilepticus. New England Journal of Medicine, 381(22), 2103\u20132113.","journal-title":"New England Journal of Medicine"},{"issue":"10231","key":"212_CR10","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/S0140-6736(20)30611-5","volume":"395","author":"JM Chamberlain","year":"2020","unstructured":"Chamberlain, J. M., Kapur, J., Shinnar, S., Elm, J., Holsti, M., Babcock, L., Rogers, A., Barsan, W., Cloyd, J., Lowenstein, D., Bleck, T. P., Conwit, R., Meinzer, C., Cock, H., Fountain, N. B., Underwood, E., Connor, J. T., Silbergleit, R., & NETT and PECARN Investigators. (2020). Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial. The Lancet, 395(10231), 1217\u20131224.","journal-title":"The Lancet"},{"key":"212_CR11","doi-asserted-by":"publisher","DOI":"10.17886\/RKI-GBE-2017-008","author":"C Heidemann","year":"2017","unstructured":"Heidemann, C., Kuhnert, R., Born, S., & Scheidt-Nave, C. (2017). 12-Monats-Pr\u00e4valenz des bekannten diabetes mellitus in Deutschland. Journal of Health Monitoring. https:\/\/doi.org\/10.17886\/RKI-GBE-2017-008","journal-title":"Journal of Health Monitoring"},{"key":"212_CR12","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1177\/003693305700200504","volume":"2","author":"J Rankin","year":"1957","unstructured":"Rankin, J. (1957). Cerebral vascular accidents in patients over the age of 60 II. Prognosis. Scottish Medical Journal, 2, 200\u2013215.","journal-title":"Scottish Medical Journal"},{"issue":"5","key":"212_CR13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases, 40(5), 373\u2013383.","journal-title":"Journal of Chronic Diseases"},{"issue":"3","key":"212_CR14","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00415-015-7992-0","volume":"263","author":"D Madzar","year":"2016","unstructured":"Madzar, D., Geyer, A., Knappe, R. U., Gollwitzer, S., Kuramatsu, J. B., Gerner, S. E., Hamer, H. M., & Huttner, H. B. (2016). Association of seizure duration and outcome in refractory status epilepticus. Journal of Neurology, 263(3), 485\u2013491.","journal-title":"Journal of Neurology"},{"issue":"2","key":"212_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/ane.13173","volume":"141","author":"I Tatlidil","year":"2020","unstructured":"Tatlidil, I., Ture, H. S., & Akhan, G. (2020). Factors affecting mortality of refractory status epilepticus. Acta Neurologica Scandinavica, 141(2), 123\u2013131.","journal-title":"Acta Neurologica Scandinavica"},{"issue":"5","key":"212_CR16","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1136\/jnnp.2005.080887","volume":"77","author":"AO Rossetti","year":"2006","unstructured":"Rossetti, A. O., Hurwitz, S., Logroscino, G., & Bromfield, E. B. (2006). Prognosis of status epilepticus: Role of etiology, age, and consciousness impairment at presentation. Journal of Neurology, Neurosurgery and Psychiatry, 77(5), 611\u2013615.","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"4","key":"212_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11886-019-1107-y","volume":"21","author":"D Glovaci","year":"2019","unstructured":"Glovaci, D., Fan, W., & Wong, N. D. (2019). Epidemiology of diabetes mellitus and cardiovascular disease. Current Cardiology Reports, 21(4), 21.","journal-title":"Current Cardiology Reports"},{"key":"212_CR18","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1159\/000357342","volume":"60","author":"E Ferriolli","year":"2014","unstructured":"Ferriolli, E., Pessanha, F. P. A. S., & Marchesi, J. C. L. S. (2014). Diabetes and exercise in the elderly. Medicine and Sport Science, 60, 122\u2013129.","journal-title":"Medicine and Sport Science"},{"issue":"9","key":"212_CR19","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1212\/01.wnl.0000269791.96189.70","volume":"69","author":"M Koubeissi","year":"2007","unstructured":"Koubeissi, M., & Alshekhlee, A. (2007). In-hospital mortality of generalized convulsive status epilepticus: A large US sample. Neurology, 69(9), 886\u2013893.","journal-title":"Neurology"},{"issue":"5","key":"212_CR20","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1111\/j.1528-1167.2012.03451.x","volume":"53","author":"V Alvarez","year":"2012","unstructured":"Alvarez, V., Januel, J. M., Burnand, B., & Rossetti, A. O. (2012). Role of comorbidities in outcome prediction after status epilepticus. Epilepsia, 53(5), e89-92.","journal-title":"Epilepsia"},{"key":"212_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.clineuro.2016.12.017","volume":"154","author":"M Belluzzo","year":"2017","unstructured":"Belluzzo, M., Furlanis, G., Stragapede, L., & Monti, F. (2017). Role of comorbidities and in-hospital complications in short-term status epilepticus outcome. Clinical Neurology and Neurosurgery, 154, 13\u201318.","journal-title":"Clinical Neurology and Neurosurgery"},{"issue":"3","key":"212_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/geriatrics4030045","volume":"4","author":"P Mendiratta","year":"2019","unstructured":"Mendiratta, P., Dayama, N., Wei, J. Y., & Prodhan, P. (2019). Status epilepticus among older adults in the United States. Geriatrics, 4(3), 45. Basel.","journal-title":"Geriatrics"},{"key":"212_CR23","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.yebeh.2018.04.027","volume":"84","author":"S Tiamkao","year":"2018","unstructured":"Tiamkao, S., Saybungkla, P., Sirikarn, P., Sawanyawisuth, K., Integrated Epilepsy Research Group. (2018). Predictors of long-term mortality in status epilepticus. Epilepsy and Behavior, 84, 114\u2013117.","journal-title":"Epilepsy and Behavior"},{"key":"212_CR24","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/ana.410380418","volume":"38","author":"O Devinsky","year":"1995","unstructured":"Devinsky, O., Leppik, I., Willmore, L. J., Pellock, J. M., Dean, C., Gates, J., & Ramsay, R. E. (1995). Safety of intravenous valproate. Annals of Neurology, 38, 670\u2013674.","journal-title":"Annals of Neurology"},{"issue":"2","key":"212_CR25","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.3390\/ijms16023820","volume":"16","author":"CY Chen","year":"2015","unstructured":"Chen, C. Y., Lee, M. Y., Lin, K. D., Hsu, W. H., Lee, Y. J., Hsiao, P. J., & Shin, S. J. (2015). Diabetes mellitus increases severity of thrombocytopenia in dengue-infected patients. International Journal of Molecular Sciences, 16(2), 3820\u20133830.","journal-title":"International Journal of Molecular Sciences"},{"issue":"9","key":"212_CR26","doi-asserted-by":"publisher","first-page":"294S","DOI":"10.1177\/1076029618808915","volume":"24","author":"M Prechel","year":"2018","unstructured":"Prechel, M., Hudec, S., Lowden, E., Escalante, V., Emanuele, N., Emanuele, M., & Walenga, J. M. (2018). Profiling heparin-induced thrombocytopenia (HIT) antibodies in hospitalized patients with and without diabetes. Clinical and Applied Thrombosis\/Hemostasis, 24(9), 294S-300S.","journal-title":"Clinical and Applied Thrombosis\/Hemostasis"},{"issue":"9","key":"212_CR27","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/adc.57.9.681","volume":"57","author":"RD Barr","year":"1982","unstructured":"Barr, R. D., Copeland, S. A., Stockwell, M. L., Morris, N., & Kelton, J. C. (1982). Valproic acid and immune thrombocytopenia. Archives of Disease in Childhood, 57(9), 681\u2013684.","journal-title":"Archives of Disease in Childhood"},{"issue":"5","key":"212_CR28","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1111\/j.1467-789X.2010.00800.x","volume":"12","author":"A Verrotti","year":"2011","unstructured":"Verrotti, A., D\u2019Egidio, C., Mohn, A., Coppola, G., & Chiarelli, F. (2011). Weight gain following treatment with valproic acid: pathogenetic mechanisms and clinical implications. Obesity Reviews, 12(5), e32-43.","journal-title":"Obesity Reviews"},{"issue":"1","key":"212_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/00048670802534341","volume":"43","author":"JL Elmslie","year":"2009","unstructured":"Elmslie, J. L., Porter, R. J., Joyce, P. R., Hunt, P. J., Shand, B. I., & Scott, R. S. (2009). Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls. Australian and New Zealand Journal of Psychiatry, 43(1), 53\u201360.","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"issue":"12","key":"212_CR30","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s40264-015-0339-z","volume":"38","author":"N Fathallah","year":"2015","unstructured":"Fathallah, N., Slim, R., Larif, S., Hmouda, H., & Saelm, C. B. (2015). Drug-induced hyperglycemia and diabetes. Drug Safety, 38(12), 1153\u20131168.","journal-title":"Drug Safety"},{"key":"212_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.biochi.2016.02.014","volume":"125","author":"S Khan","year":"2016","unstructured":"Khan, S., Kumar, S., & Jena, G. (2016). Valproic acid reduces insulin-resistance, fat deposition and FOXO1-mediated gluconeogenesis in type-2 diabetic rat. Biochemie, 125, 42\u201352.","journal-title":"Biochemie"},{"issue":"3","key":"212_CR32","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s13105-011-0088-0","volume":"67","author":"A Terasmaa","year":"2011","unstructured":"Terasmaa, A., Soomets, U., Oflijan, J., Punapart, M., Hansen, M., Matto, V., Ehrlich, K., Must, A., Koks, S., & Vasar, E. (2011). Wfs1 mutation makes mice sensitive to insulin-like effect of acute valproic acid and resistant to streptozocin. Journal of Physiology and Biochemistry, 67(3), 381\u2013390.","journal-title":"Journal of Physiology and Biochemistry"},{"issue":"1","key":"212_CR33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00535-006-1961-4","volume":"42","author":"T Gerstner","year":"2007","unstructured":"Gerstner, T., B\u00fcsing, D., Bell, N., Longin, E., Kasper, J. M., Klostermann, W., Hebing, B., Hanefeld, F., Eckel, Z., Hoffman, R., Bettendorf, U., Weidner, B., Wiemer-Kruel, A., Brockmann, K., Neumann, F. W., Sandrieser, T., Wolff, M., & K\u00f6nig, S. (2007). Valproic acid-induced pancreatitis: 16 new cases and a review of the literature. Journal of Gastroenterology, 42(1), 39\u201348.","journal-title":"Journal of Gastroenterology"},{"issue":"12","key":"212_CR34","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1592\/phco.21.20.1549.34480","volume":"21","author":"SA Chapman","year":"2001","unstructured":"Chapman, S. A., Wacksman, G. P., & Patterson, B. D. (2001). Pancreatitis associated with valproic acid: A review of the literature. Pharmacotherapy, 21(12), 1549\u20131560.","journal-title":"Pharmacotherapy"},{"issue":"11","key":"212_CR35","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41574-020-00409-6","volume":"16","author":"DL Eizirik","year":"2020","unstructured":"Eizirik, D. L., & Colli, M. L. (2020). Revisiting the role of inflammation in the loss of pancreatic \u03b2-cells in T1DM. Nature Reviews Endocrinology, 16(11), 611\u2013612.","journal-title":"Nature Reviews Endocrinology"},{"issue":"3","key":"212_CR36","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/ane.12867","volume":"137","author":"L Vilella","year":"2018","unstructured":"Vilella, L., Gonzalez Cuevas, M., Quintana Luque, M., Toledo, M., Sueiras Gil, M., Guzman, L., Salas Puig, J., & Santamarina, P. E. (2018). Prognosis of status epilepticus in elderly patients. Acta Neurologica Scandinavica, 137(3), 321\u2013328.","journal-title":"Acta Neurologica Scandinavica"},{"issue":"11","key":"212_CR37","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1001\/archneur.62.11.1698","volume":"62","author":"AO Rossetti","year":"2005","unstructured":"Rossetti, A. O., Logroscino, G., & Bromfield, E. B. (2005). Refractory status epilepticus: Effect of treatment aggressiveness on prognosis. Archives of Neurology, 62(11), 1698\u20131702.","journal-title":"Archives of Neurology"},{"issue":"1","key":"212_CR38","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/epi.14607","volume":"60","author":"M Leitinger","year":"2019","unstructured":"Leitinger, M., Trinka, E., Giovannini, G., Zimmermann, G., Florea, C., Rohracher, A., Kalss, G., Neuray, C., Kreidenhuber, R., H\u00f6fler, J., Kuchukhidze, G., Granbickler, C., Dobesberger, J., Novak, H. F., Pilz, G., Meletti, S., & Siebert, U. (2019). Epidemiology of status epilepticus in adults: A population-based study on incidence, causes, and outcomes. Epilepsia, 60(1), 53\u201362.","journal-title":"Epilepsia"},{"key":"212_CR39","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1111\/j.1528-1167.2011.03056.x","volume":"52","author":"V Alvarez","year":"2011","unstructured":"Alvarez, V., Januel, J. M., Burnand, B., & Rossetti, A. O. (2011). Second-line status epilepticus treatment: Comparison of phenytoin, valproate, and levetiracetam. Epilepsia, 52, 1292\u20131296.","journal-title":"Epilepsia"},{"issue":"10","key":"212_CR40","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1111\/ene.13073","volume":"23","author":"M Gonzalez-Cuevas","year":"2016","unstructured":"Gonzalez-Cuevas, M., Santamarina, E., Toledo, M., Quintana, M., Sala, J., Sueiras, M., Guzman, L., & Salas-Puig, J. (2016). A new clinical score for the prognosis of status epilepticus in adults. European Journal of Neurology, 23(10), 1534\u20131540.","journal-title":"European Journal of Neurology"},{"key":"212_CR41","unstructured":"Fachinformation Sanofi Ergenyl intraven\u00f6s (2021). https:\/\/mein.sanofi.de\/produkte\/Ergenyl-intravenoes-Vial\/Downloads?id=22df894a-0ef1-461d-be30-3647c0cd07d5."},{"key":"212_CR42","unstructured":"Gebrauchsinformation Orfiril 100mg\/ml Infusionsl\u00f6sung (2021). https:\/\/www.desitin.de\/wp-content\/uploads\/2019\/09\/Orfiril_i.v_GI.pdf."},{"issue":"5","key":"212_CR43","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1001\/jamaneurol.2021.0520","volume":"78","author":"EL Guterman","year":"2021","unstructured":"Guterman, E. L., Betjemann, J. P., Aimetti, A., Li, J. W., Wang, Z., Yin, D., Hulihan, J., Lyons, T., Mivasato, G., & Strzelczyk, A. (2021). Association between treatment progression, disease refractoriness, and burden of illness among hospitalized patients with status epilepticus. JAMA Neurology, 78(5), 588\u2013595.","journal-title":"JAMA Neurology"},{"issue":"12","key":"212_CR44","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1111\/epi.13584","volume":"57","author":"LM Kortland","year":"2016","unstructured":"Kortland, L. M., Alfter, A., B\u00e4hr, O., Carl, B., Dodel, R., Freiman, T. M., Hubert, K., Jahnke, K., Knake, S., von Podewils, F., Reese, J. P., Runge, U., Senft, C., Steinmetz, H., Rosenow, F., & Strzelczyk, A. (2016). Costs and cost-driving factors for acute treatment of adults with status epilepticus: A multicenter cohort study from Germany. Epilepsia, 57(12), 2056\u20132066.","journal-title":"Epilepsia"}],"container-title":["Neurological Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-022-00212-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42466-022-00212-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-022-00212-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T22:03:51Z","timestamp":1668117831000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurolrespract.biomedcentral.com\/articles\/10.1186\/s42466-022-00212-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,24]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["212"],"URL":"https:\/\/doi.org\/10.1186\/s42466-022-00212-w","relation":{},"ISSN":["2524-3489"],"issn-type":[{"value":"2524-3489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,24]]},"assertion":[{"value":"4 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics committee of the University Leipzig (05\/2021; Reference 227\/21-ek). Due to the retrospective and non-interventional design patients were not contacted and only data of past hospital stays were used. The need for informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}